61 related articles for article (PubMed ID: 20089519)
1. Apolipoproteins in the discrimination of atherosclerotic burden and cardiac function in patients with stable coronary artery disease.
Patel JV; Abraheem A; Creamer J; Gunning M; Hughes EA; Lip GY
Eur J Heart Fail; 2010 Mar; 12(3):254-9. PubMed ID: 20089519
[TBL] [Abstract][Full Text] [Related]
2. LDL molecular size as risk factor in coronary artery disease.
Kozma L; Fodor J; Chockalingam A; Sussex B
Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
[TBL] [Abstract][Full Text] [Related]
3. Relationship between bilirubin, apolipoprotein B, and coronary artery disease.
Levinson SS
Ann Clin Lab Sci; 1997; 27(3):185-92. PubMed ID: 9142370
[TBL] [Abstract][Full Text] [Related]
4. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
Bukowska H
Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
[TBL] [Abstract][Full Text] [Related]
5. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
6. Apolipoproteins as markers and managers of coronary risk.
Chan DC; Watts GF
QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
[TBL] [Abstract][Full Text] [Related]
7. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.
Wang XL; Liu SX; McCredie RM; Wilcken DE
J Clin Invest; 1996 Jul; 98(2):372-7. PubMed ID: 8755647
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
10. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
11. Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis.
Levinson SS
Am J Clin Pathol; 2007 Mar; 127(3):449-55. PubMed ID: 17276939
[TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
[TBL] [Abstract][Full Text] [Related]
13. Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease.
Lee BJ; Lin JS; Lin YC; Lin PT
Lipids Health Dis; 2016 Jun; 15():107. PubMed ID: 27317162
[TBL] [Abstract][Full Text] [Related]
14. Serum lipid pattern and apolipoproteins (A1 and B100) in active rheumatoid arthritis.
Magarò M; Altomonte L; Zoli A; Mirone L; Ruffini MP
Z Rheumatol; 1991; 50(3):168-70. PubMed ID: 1927062
[TBL] [Abstract][Full Text] [Related]
15. [Indicators of atherosclerosis risk. Evaluation with coronary angiography in non diabetic men with total cholesterol levels equal to or below 240 mg/dl].
Arteaga A; Martínez A; Pollak F; Borghesi L; Catalán L; Acosta AM; Leighton F
Rev Med Chil; 1995 Feb; 123(2):145-57. PubMed ID: 7569454
[TBL] [Abstract][Full Text] [Related]
16. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
[TBL] [Abstract][Full Text] [Related]
17. [Changes of blood lipids and apolipoproteins in patients with silent myocardial ischemia].
Tan M; Zhao S; Yu S
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):44-6, 56. PubMed ID: 10681793
[TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein particles LpA-I, LpA-I: A-II and LpB in coronary artery disease].
Calvo C; Olmos A; Ulloa N; Bustos A; Toledo L; Durán D; Naveas R
Rev Med Chil; 2000 Jan; 128(1):9-16. PubMed ID: 10883517
[TBL] [Abstract][Full Text] [Related]
19. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
20. Optimized automated apolipoprotein A-I assays as markers for coronary artery disease.
Levinson SS; Hobbs GA
Arch Pathol Lab Med; 1997 Jul; 121(7):678-84. PubMed ID: 9240901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
